US Patent Issued to SIMCERE PHARMACEUTICAL, JIANGSU SIMCERE PHARMACEUTICAL on May 19 for "Use of composition in treatment of cerebral stroke" (Chinese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,353, issued on May 19, was assigned to SIMCERE PHARMACEUTICAL Co. LTD. (Jiangsu, China) and JIANGSU SIMCERE PHARMACEUTICAL Co. LTD (Jiangsu, China).

"Use of composition in treatment of cerebral stroke" was invented by Xiaofei Feng (Jiangsu, China), Shunwei Zhu (Shanghai), Cuncun Liu (Jiangsu, China), Feng Wang (Jiangsu, China) and Jinsheng Ren (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Use of a composition in preparation of a drug for treating a patient suffering from a cerebral stroke. The composition includes edaravone and dexborneol, and the patient has a history of hypertension."

The patent was filed on July 7, 2021, under Ap...